Delivery Order SPE2DB25D3005-SPE2DB25FQHLB
- Not listed
- The Defense Logistics Agency awarded a $14,672.56 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count). The contract is structured as a firm fixed price delivery order with a completion date of July 25, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this competitively awarded contract. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,675.75 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30-count), with a firm fixed price and an ultimate completion date of July 28, 2025. This non-set-aside, competitively awarded contract was issued on July 25, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $5,083.49 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in unit dose packaging (30 count) under a firm fixed price contract. This delivery order, which was competitively awarded with no set-aside designation, was executed on July 23, 2025, with an ultimate completion date of July 24, 2025. Performance will take place at the contractor's Corporate Office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packages of 30, with a ceiling value of $5,627.91. This is a firm fixed-price delivery order contract with an ultimate completion date of July 21, 2025, and represents a competitive award with no set-aside designation. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $5,086.20 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30 count) on July 30, 2025, with completion targeted for July 31, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Telmisartan-HCZ 80-25 mg tablets (unit dose, 30-count packages) valued at $3,031.71. This non-set-aside, competitively awarded delivery order, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a firm fixed-price pharmaceutical supply transaction supporting federal medical procurement needs. The product will be delivered to AmerisourceBergen's corporate office...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Telmisartan-HCTZ 80-25 mg tablets. The contract has a ceiling value of $3,798.38 and a period of performance through July 11, 2025. The award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Telmisartan 80 mg tablets (30-count package) on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price contract carries a ceiling value of $1,270.22 and represents a non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,007.04 to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packages of 30 units. This competitive award, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's...
- This delivery order, awarded to AmerisourceBergen Drug Corp on July 25, 2025, procures Telmisartan-HCTZ 80-25 mg tablets in unit-dose packaging (30 count) for the Defense Logistics Agency (DLA) at a firm fixed price of $1,243.56. The contract is not set-aside and represents a competitive award for pharmaceutical supply to support federal medical procurement needs. Performance will be completed by July 28, 2025, with delivery to AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB25D3005Indefinite Delivery Contract
- SPE2DB25D3005-SPE2DB25FQHLBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30-count), with a ceiling value of $9,953.41. This delivery order is a firm fixed price contract with no set-aside designation, reflecting competitive award status. The contract is scheduled for ultimate completion by August 1, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. Through this prime IDC, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The current delivery order for this antihypertensive medication represents a routine component of the company's extensive portfolio of pharmaceutical deliveries to support federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.0k | 7/31/25 |